Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922867 · ClinicalTrials.gov registry record · NA
Web-based CBT for Insomnia Patients With Fibromyalgia
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03922867: Completed NA study, sponsored by Mayo Clinic.
NCT03922867 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03922867, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Researchers are evaluating if cognitive behavioral therapy for insomnia delivered over the internet will help with fibromyalgia symptoms.
Primary Outcome
Surveying the changes in insomnia severity seen during the subjects participation in the study
Interventions
- BEHAVIORAL CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-12-03 |
| Est. Completion | 2021-03-03 |
| Phase | NA |
What the finished NCT03922867 record still lists
NCT03922867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which CBT is the first listed.
NCT03922867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03922867 about?
NCT03922867 is a clinical study titled "Web-based CBT for Insomnia Patients With Fibromyalgia". Researchers are evaluating if cognitive behavioral therapy for insomnia delivered over the internet will help with fibromyalgia symptoms.
What is the current status of trial NCT03922867?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-12-03. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT03922867?
The interventions under investigation include: CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03922867?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03922867's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI